Can the drug-driven dependency and deprivation effect be used as a therapeutic tool in tuberculous patients?
André
Nicolas
N
Pasquier
Eddy
E
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology; D014376:Tuberculosis / Q000188:drug therapy* / Q000503:physiopathology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000503:physiopathology
D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D012293:Rifampin